Longevity Funds International
Finance · 1-10 Employees
View Company Info for Free
Overview
Website
www.longevity.vcRevenue
<$5 MillionIndustry
About Longevity Funds International
The Longevity Fund is a venture capital firm established in 2011, focused on funding companies that develop drugs for age-related diseases and longevity. The firm aims to support mission-oriented founders who are dedicated to creating innovative solutions in the longevity space. With a vision to bring longevity drugs into mainstream medicine, The Longevity Fund is positioned to play a pivotal role in the evolution of this emerging industry. Their investment strategy emphasizes the importance of unconventional backgrounds and a deep commitment to the field among founders.Explore more
Longevity Funds International Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Longevity Funds International
Compare insights from companies similar to Longevity Funds International, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Longevity Funds International Tech Stack
A closer look at the technologies used by Longevity Funds International
See more technologies
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Longevity Funds International
Sign Up For FreeTo access detailed company insights
The Longevity Fund is a venture capital firm established in 2011, focused on funding companies that develop drugs for age-related diseases and longevity. The firm aims to support mission-oriented founders who are dedicated to creating innovative solutions in the longevity space. With a vision to bring longevity drugs into mainstream medicine, The L... Read More
